Next, the neutralization experiment performed on JURL-MK1 cells (Figure 1b) was repeated (with the same TCMs) on primary human CD34+ CML stem/progenitor cells (Figure 5). This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.